Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

BILATERAL NANOPHTHALMIC UVEAL EFFUSION SYNDROME: CLINICAL PRESENTATION AND SURGICAL MANAGEMENT

Abell, Robin G., MBBS*; Kerr, Nathan M., MBChB; Vote, Brendan J., FRANZCO*,†

doi: 10.1097/ICB.0b013e318297f6c1
Case Report: PDF Only

Purpose: To describe the clinical presentation and surgical management of bilateral uveal effusion syndrome in a type 1 diabetic patient with nanophthalmos.

Methods: A 38-year-old man presented with decreased visual acuity. Fundus examination revealed exudative retinal detachment and choroidal folding. Ultrasound examination confirmed thickened sclera, choroidal effusion, and nanophthalmos. Partial thickness scleral windows and subscleral sclerectomy were performed. The patient returned 2 years postoperatively with the same presentation in the contralateral eye.

Results: After subscleral sclerectomy, intraocular pressure remained stable and the patient recovered premorbid vision in both eyes. At 4 years of follow-up, the patient’s vision had remained stable without the need for further treatment.

Conclusion: The association of uveal effusion syndrome with diabetes and other autoimmune disorders is unclear, warranting further research. Uveal effusion syndrome can be managed effectively by partial thickness scleral windows and sclerectomy with improvement and maintenance of visual acuity.

The association of uveal effusion syndrome with diabetes and other autoimmune disorders is unclear, warranting further research. Uveal effusion syndrome can be managed effectively by partial thickness scleral windows and sclerectomy with improvement and maintenance of visual acuity.

*Launceston Eye Institute, Tasmania, Australia; and

Tasmanian Eye Institute, Tasmania, Australia.

Reprint requests: Brendan J. Vote, Launceston Eye Institute, 36 Thistle Street West, Launceston 7250, Australia; e-mail: eye.vote@bigpond.net.au

None of the authors have any financial/conflicting interests to disclose.

© 2018 by Ophthalmic Communications Society, Inc.